Stonegate Investment Group’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-32,621
Closed -$124K – 416
2024
Q4
$124K Buy
+32,621
New +$176K ﹤0.01% 344
2023
Q1
– Sell
-10,940
Closed -$76.5K – 353
2022
Q4
$76.5K Sell
10,940
-5,266
-32% -$54.2K ﹤0.01% 297
2022
Q3
$144K Sell
16,206
-552
-3% -$6.37K 0.01% 274
2022
Q2
$173K Buy
16,758
+5,903
+54% +$87.7K 0.01% 276
2022
Q1
$226K Sell
10,855
-2,211
-17% -$48.2K 0.01% 233
2021
Q4
$334K Buy
+13,066
New +$361K 0.01% 202

Other funds holding MSOS

Stonegate Investment Group's MSOS Position: Q1 2025 in Review

Stonegate Investment Group sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q1 2025, closing a stake of 32,621 shares — an estimated $124K sold.

Stonegate Investment Group first reported a position in MSOS in Q4 2021 and held it in 6 quarters. The position peaked at $334K in Q4 2021. 157 funds tracked by Wall St. Rank hold MSOS as of Q1 2025.

  • Stonegate Investment Group reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q1 2025 after selling out during the quarter.
  • Stonegate Investment Group sold 32,621 AdvisorShares Pure US Cannabis ETF shares in Q1 2025, an estimated $124K.
  • Stonegate Investment Group first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2021 and held it in 6 quarters.
  • Stonegate Investment Group's AdvisorShares Pure US Cannabis ETF position peaked at $334K in Q4 2021.
  • 157 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2025.

Based on Stonegate Investment Group's 13F filing for Q1 2025, filed 22 Apr 2025.